CGIX
CGIX - Huge Volume Push - Momentum With BullsCancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.
SHORT INTEREST
1.33M 09/13/19
P/E Current
-0.15
P/E Ratio (with extraordinary items)
-0.31
Average Recommendation: HOLD
Average Target Price: 3.00
CGIX Stock. Price PredictionOnce the price breaks above the 0.29 level, I would recommend buying the stock and holding it till the given targets are reached
CGIX POTENTIAL HARMONIC PATTERN FORMATIONCGIX has broken the long term trendline with a strong impulse. I'm expecting more upside for this potential harmonic pattern formation before a bigger correction.